Congestive heart failure is a frequent complication of hypertension. This is a brief review of the mechanisms precipitating heart failure, as well as the various approaches to treatment of this complication. Emphasis is given to the rationale for treating congestive heart failure with vasodilation and by chronic angiotensin-converting enzyme inhibition with captopril. A summary is presented of clinical experience with this agent over the past few years together with an outline of the characteristics that make it different from pharmacologic vasodilators
AbstractDuring the past 10 years, more than 80 orally active vasodilator and inotropic agents have b...
It is argued that the basis of therapy in a patient with mild-to-moderate congestive heart failure s...
The most important recent advance in the medical management of patients with acute and chronic conge...
Congestive heart failure is a frequent complication of hypertension. This is a brief review of the m...
When congestive heart failure occurs, cardiac output decreases and left ventricular end-diastolic pr...
Catopril, an inhibitor of angiotensin converting enzyme, was given orally during cardiac catheterisa...
Oral vasodilators have proved to be valuable drugs in the management of systolic or diastolic conges...
Studies using a competitive inhibitor of angiotensin II (saralasin) or converting enzyme inhibitors ...
Abstract Heart failure is one of the major problems related to heart diseases in the modern era. Mul...
Studies using a competitive inhibitor of angiotensin II (saralasin) or converting enzyme inhibitors ...
Therapy of heart failure. The incidence and prevalence of heart failure is on the rise. It has becom...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
The idea of vasodilator therapy for heart failure has been toyed with for almost one hundred years, ...
To alter the natural history of congestive heart failure and change the poor prognosis for patients ...
SUMMARY The effect of the converting enzyme inhibitor captopril as long term treatment was investiga...
AbstractDuring the past 10 years, more than 80 orally active vasodilator and inotropic agents have b...
It is argued that the basis of therapy in a patient with mild-to-moderate congestive heart failure s...
The most important recent advance in the medical management of patients with acute and chronic conge...
Congestive heart failure is a frequent complication of hypertension. This is a brief review of the m...
When congestive heart failure occurs, cardiac output decreases and left ventricular end-diastolic pr...
Catopril, an inhibitor of angiotensin converting enzyme, was given orally during cardiac catheterisa...
Oral vasodilators have proved to be valuable drugs in the management of systolic or diastolic conges...
Studies using a competitive inhibitor of angiotensin II (saralasin) or converting enzyme inhibitors ...
Abstract Heart failure is one of the major problems related to heart diseases in the modern era. Mul...
Studies using a competitive inhibitor of angiotensin II (saralasin) or converting enzyme inhibitors ...
Therapy of heart failure. The incidence and prevalence of heart failure is on the rise. It has becom...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
The idea of vasodilator therapy for heart failure has been toyed with for almost one hundred years, ...
To alter the natural history of congestive heart failure and change the poor prognosis for patients ...
SUMMARY The effect of the converting enzyme inhibitor captopril as long term treatment was investiga...
AbstractDuring the past 10 years, more than 80 orally active vasodilator and inotropic agents have b...
It is argued that the basis of therapy in a patient with mild-to-moderate congestive heart failure s...
The most important recent advance in the medical management of patients with acute and chronic conge...